KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Investing Activities: 2015-2025

Historic Cash from Investing Activities for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to -$10.7 million.

  • Medpace Holdings' Cash from Investing Activities fell 1.66% to -$10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.2 million, marking a year-over-year decrease of 19.09%. This contributed to the annual value of -$28.3 million for FY2024, which is 18.25% up from last year.
  • Per Medpace Holdings' latest filing, its Cash from Investing Activities stood at -$10.7 million for Q3 2025, which was down 77.08% from -$6.0 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Cash from Investing Activities ranged from a high of $2.5 million in Q1 2024 and a low of -$12.8 million during Q2 2024.
  • Over the past 3 years, Medpace Holdings' median Cash from Investing Activities value was -$8.7 million (recorded in 2023), while the average stood at -$8.1 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first spiked by 126.62% in 2024, then plummeted by 494.74% in 2025.
  • Quarterly analysis of 5 years shows Medpace Holdings' Cash from Investing Activities stood at -$9.1 million in 2021, then fell by 1.14% to -$9.2 million in 2022, then rose by 13.26% to -$8.0 million in 2023, then increased by 5.44% to -$7.6 million in 2024, then dropped by 1.66% to -$10.7 million in 2025.
  • Its Cash from Investing Activities was -$10.7 million in Q3 2025, compared to -$6.0 million in Q2 2025 and -$10.0 million in Q1 2025.